📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Loading analysis...
CRISIL Reaffirms Mangalam Organics Credit Ratings at BBB+; Maintains 'Watch Developing' Status
CRISIL Ratings has reaffirmed the credit ratings for Mangalam Organics Limited's bank facilities totaling Rs. 397 Crore. The long-term rating is maintained at CRISIL BBB+ and the short-term rating at CRISIL A2. Both ratings continue to be on 'Rating Watch with Developing Implications', indicating that the credit profile is under close monitoring for potential future changes. The rated facilities include a mix of cash credit, letters of credit, and term loans across several major banks.
Key Highlights
Total bank loan facilities reaffirmed at Rs. 397 Crore
Long-term rating maintained at CRISIL BBB+ and short-term at CRISIL A2
Ratings continue on 'Rating Watch with Developing Implications' status
Major facility allocations include Axis Bank (Rs. 125 Cr) and HDFC Bank (Rs. 92.5 Cr)
Facilities include Rs. 169.5 Crore in Cash Credit and Rs. 100 Crore in Letters of Credit
💼 Action for Investors
Investors should monitor the company's upcoming financial performance and any news regarding the resolution of the 'Rating Watch' status. While the reaffirmation shows stability, the 'Developing Implications' tag suggests potential volatility in the credit profile.
Loading analysis...
Mangalam Organics Q3 FY26 Revenue Jumps 32.6% YoY to ₹164.3 Cr; PAT Up 19.6%
Mangalam Organics reported a strong 32.58% YoY revenue growth in Q3 FY26, reaching ₹164.29 crore, driven by volume growth and lower input costs. Net profit for the quarter rose 19.56% to ₹4.34 crore, although margins saw a slight contraction with EBITDA margin at 11.75%. The company successfully completed its Bhimseni/Isoborneol Flakes expansion to 2,500 MTPA in 2025. The retail segment, Mangalam Brands, showed significant EBITDA growth of 252% YoY, contributing ₹55.9 crore to the top line.
Key Highlights
Revenue from operations grew 32.58% YoY to ₹164.29 crore in Q3 FY26.
PAT increased by 19.56% YoY to ₹4.34 crore, while full-year FY25 PAT surged 197% to ₹12.50 crore.
Successfully completed expansion of Bhimseni/Isoborneol Flakes capacity to 2,500 MT per annum in 2025.
Retail subsidiary Mangalam Brands reported a 252% YoY increase in EBITDA to ₹6.9 crore for the quarter.
B2B Terpene operations remain the dominant segment, contributing 96% of the company's revenue.
💼 Action for Investors
Investors should monitor the scaling of the newly expanded Bhimseni capacity and the improving profitability of the B2C retail segment. The stock remains a play on pine chemistry and domestic camphor demand, though margin volatility due to raw material costs remains a key risk.
Loading analysis...
Mangalam Organics Q3 Consolidated Net Profit Rises 19% YoY to ₹4.34 Crore
Mangalam Organics reported a strong consolidated performance for Q3 FY26, with revenue from operations growing 32.6% YoY to ₹164.30 crore. Consolidated net profit increased to ₹4.34 crore from ₹3.64 crore in the same quarter last year, driven by robust subsidiary performance. However, standalone results showed a significant decline in net profit to ₹1.11 crore compared to ₹2.83 crore YoY, indicating margin pressure on the core manufacturing business. The company's consolidated EPS improved to ₹5.07 from ₹4.25 in the year-ago period.
Key Highlights
Consolidated Revenue from Operations grew 32.6% YoY to ₹164.30 crore from ₹123.92 crore.
Consolidated Net Profit increased by 19.3% YoY to ₹4.34 crore.
Standalone Net Profit declined by 60.8% YoY to ₹1.11 crore, reflecting higher operational costs.
Consolidated EPS for the quarter rose to ₹5.07 compared to ₹4.25 in Q3 FY25.
Nine-month consolidated profit reached ₹19.76 crore, a significant jump from ₹7.43 crore in the previous year.
💼 Action for Investors
Investors should focus on the consolidated growth which suggests that the company's brand and retail-focused subsidiaries are scaling effectively. Monitor the standalone segment for potential recovery in margins as the core chemical business currently appears to be a drag on overall profitability.
Loading analysis...
Mangalam Organics Q3 Consolidated Net Profit Rises 19% YoY to ₹4.34 Cr; Revenue Up 33%
Mangalam Organics reported a strong consolidated performance for Q3 FY26, with revenue from operations growing 32.6% YoY to ₹164.30 crore. Consolidated net profit increased by 19.3% YoY to ₹4.34 crore, showing resilience despite a sharp drop in 'Other Income' compared to the previous quarter. For the nine-month period ended December 2025, the company's consolidated net profit surged to ₹19.76 crore from ₹7.43 crore in the previous year, indicating a significant operational turnaround. However, standalone margins faced pressure, with standalone net profit declining YoY to ₹1.11 crore.
Key Highlights
Consolidated Revenue from operations grew 32.6% YoY to ₹164.30 crore in Q3 FY26.
Consolidated Net Profit (Total Comprehensive Income) rose 19.3% YoY to ₹4.34 crore.
9M FY26 Consolidated Net Profit surged to ₹19.76 crore compared to ₹7.43 crore in 9M FY25.
Consolidated EPS improved to ₹5.07 for the quarter from ₹4.25 in the same quarter last year.
Standalone revenue grew 21.8% YoY to ₹122.45 crore, though standalone net profit dipped to ₹1.11 crore.
💼 Action for Investors
Investors should focus on the robust consolidated growth which suggests strong performance in subsidiaries and the core chemical segment. Monitor raw material cost trends as they remain the largest expense component impacting standalone margins.
Loading analysis...
Mangalam Organics Q3 FY26 Consolidated Net Profit Rises 19% YoY to ₹4.34 Crore
Mangalam Organics reported a strong 32.6% YoY growth in consolidated revenue from operations, reaching ₹164.30 crore for the quarter ended December 31, 2025. Consolidated net profit increased by 19.3% YoY to ₹4.34 crore, despite a significant drop in other income compared to the previous quarter. The nine-month performance shows a robust recovery, with consolidated net profit surging 166% to ₹19.76 crore. However, standalone margins appear under pressure, with standalone net profit declining YoY, suggesting that growth is being driven by its subsidiaries and retail brands.
Key Highlights
Consolidated Revenue from Operations grew 32.6% YoY to ₹164.30 crore in Q3 FY26.
Consolidated Net Profit for the quarter stood at ₹4.34 crore versus ₹3.64 crore in Q3 FY25.
Nine-month consolidated net profit surged to ₹19.76 crore from ₹7.43 crore in the previous year period.
Consolidated EPS improved to ₹5.07 for the quarter, up from ₹4.25 YoY.
Standalone net profit declined to ₹1.11 crore from ₹2.83 crore YoY, indicating margin pressure at the parent level.
💼 Action for Investors
Investors should take note of the strong consolidated growth driven by subsidiaries, which offsets the weakness in standalone operations. Monitor the sustainability of the 9-month growth trajectory and the company's ability to manage raw material costs in the chemical segment.